Immunogenicity And Reactogenicity Of Bnt162B2 Covid-19 Mrna Vaccine In Long-Survivor (Ls) Patients With Metastatic Lung Cancer (Mlc) After Primary Immunization (Pv) And Booster (Bd): Covalence Study
Bnt162B2 COVID-19 mRNA Vaccine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Immunogenicity And Reactogenicity Of Bnt162B2 Covid-19 Mrna Vaccine In Long-Survivor (Ls) Patients With Metastatic Lung Cancer (Mlc) After Primary Immunization (Pv) And Booster (Bd): Covalence Study ### Output: Bnt162B2 COVID-19 mRNA Vaccine